Literature DB >> 24008762

SUMO-specific protease 2 suppresses cell migration and invasion through inhibiting the expression of MMP13 in bladder cancer cells.

Ming-Yue Tan1, Xing-Yu Mu, Bin Liu, Yong Wang, Er-Dun Bao, Jian-Xin Qiu, Yu Fan.   

Abstract

BACKGROUND: SUMO-specific protease 2 (SENP2) is a de-SUMOylation protease family member which has an indispensable role in the regulation of NF-κB transcriptional activation and Wnt signaling. However, whether SENP2 plays a role in tumor metastasis is completely unknown.
METHODS: Real-time PCR and Western blot was used to detect the expression of SENP2 in human bladder cancer samples and cell lines. Small interfering RNA (siRNA) was used to silencing the expression of SENP2. Matrigel-coated invasion chambers were used to detect the invasion ability of SENP2 in bladder cancer cells.
RESULTS: SENP2 was down-regulated in bladder cancer samples. SENP2 inhibited bladder cancer cells migration and invasion in vitro. Transcriptional analysis of several genes associated with tumor metastasis and invasion demonstrated that SENP2 selectively down-regulated MMP13 in bladder cancer cells. Further analysis indicated that silencing of MMP13 rescued the invasive phenotype in SENP2 expressing T24 cells.
CONCLUSION: SENP2 functions as a tumor metastasis suppressor in bladder cancer. The effects of SENP2 on bladder cancer invasion are partially mediated by inhibiting the expression of MMP13.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24008762     DOI: 10.1159/000354458

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  17 in total

1.  Chronic Ethanol-Induced Impairment of Wnt/β-Catenin Signaling is Attenuated by PPAR-δ Agonist.

Authors:  Chelsea Q Xu; Suzanne M de la Monte; Ming Tong; Chiung-Kuei Huang; Miran Kim
Journal:  Alcohol Clin Exp Res       Date:  2015-04-23       Impact factor: 3.455

2.  Regulation of metastasis of bladder cancer cells through the WNT signaling pathway.

Authors:  Yiheng Du; Yongchuan Wang; Fei Zhang; Wenbo Wu; Wei Wang; Hao Li; Shujie Xia; Haitao Liu
Journal:  Tumour Biol       Date:  2015-06-12

Review 3.  Targeting nuclear thymidylate biosynthesis.

Authors:  James Chon; Patrick J Stover; Martha S Field
Journal:  Mol Aspects Med       Date:  2016-11-19

Review 4.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

5.  SUMO-specific protease 2 (SENP2) functions as a tumor suppressor in osteosarcoma via SOX9 degradation.

Authors:  Hong Pei; Liang Chen; Quan-Ming Liao; Ke-Jun Wang; Shun-Guang Chen; Zheng-Jie Liu; Zhi-Cai Zhang
Journal:  Exp Ther Med       Date:  2018-10-09       Impact factor: 2.447

Review 6.  Regulation of SUMOylation Targets Associated With Wnt/β-Catenin Pathway.

Authors:  Linlin Fan; Xudong Yang; Minying Zheng; Xiaohui Yang; Yidi Ning; Ming Gao; Shiwu Zhang
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

7.  SENP2 regulated the stability of β-catenin through WWOX in hepatocellular carcinoma cell.

Authors:  Qing-Feng Jiang; Yu-Wei Tian; Quan Shen; Huan-Zhou Xue; Ke Li
Journal:  Tumour Biol       Date:  2014-06-27

8.  Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.

Authors:  Alicja Mirecka; Zbigniew Morawiec; Katarzyna Wozniak
Journal:  Pathol Oncol Res       Date:  2016-05-13       Impact factor: 3.201

9.  SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1.

Authors:  Mingyue Tan; Hua Gong; Jun Wang; Le Tao; Dongliang Xu; Erdun Bao; Zhihong Liu; Jianxin Qiu
Journal:  Sci Rep       Date:  2015-09-15       Impact factor: 4.379

Review 10.  SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer.

Authors:  Karolin Eifler; Alfred C O Vertegaal
Journal:  Trends Biochem Sci       Date:  2015-10-22       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.